Inventor · disambiguated record
Edgar Haber
Also filed as: HABER EDGAR
32 granted patents·3 pending applications·1,435 citations·filing 1976–2007
98Inventor score
Files withGEN HOSPITAL CORP16HARVARD COLLEGE9MASSACHUSETTS GEN HOSPITAL5IONICS2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
35 records- 0199US4036945AComposition and method for determining the size and location of myocardial infarctsMASSACHUSETTS GEN HOSPITAL·Filed 1976·Granted Jul 19, 1977·646 cites·6 claims
- 0294US4584075AProcess and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrierIONICS·Filed 1984·Granted Apr 22, 1986·96 cites·9 claims
- 0388US4421735ARadiolabeled diagnostic compositions and method for making the sameMASSACHUSETTS GEN HOSPITAL·Filed 1980·Granted Dec 20, 1983·73 cites·14 claims
- 0488US4355023AAntibody fragment compositions and processMASSACHUSETTS GEN HOSPITAL·Filed 1980·Granted Oct 19, 1982·86 cites·9 claims
- 0584US4927916AMethod of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptidesGEN HOSPITAL CORP·Filed 1986·Granted May 22, 1990·55 cites·3 claims
- 0682US5888765AEndothelial-cell specific promoterHARVARD COLLEGE·Filed 1995·Granted Mar 30, 1999·47 cites·10 claims
- 0782US5571523AAntioxidant-induced apoptosis in vascular smooth muscle cellsHARVARD COLLEGE·Filed 1995·Granted Nov 5, 1996·70 cites·16 claims
- 0880US4332787AAssay for beta-adrenergic antagonists and antibody thereforMASSACHUSETTS GEN HOSPITAL·Filed 1980·Granted Jun 1, 1982·45 cites·14 claims
- 0976US5582862AAntibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1992·Granted Dec 10, 1996·26 cites·13 claims
- 1075US4661224AProcess and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrierIONICS·Filed 1986·Granted Apr 28, 1987·38 cites·9 claims
- 1173US4916070AFibrin-specific antibodies and method of screening for the antibodiesGEN HOSPITAL CORP·Filed 1986·Granted Apr 10, 1990·44 cites·7 claims
- 1266US4478827ARenin inhibitorsGEN HOSPITAL CORP·Filed 1983·Granted Oct 23, 1984·22 cites·6 claims
- 1366US4269827AProcess and composition for reducing blood pressureMASSACHUSETTS GEN HOSPITAL·Filed 1980·Granted May 26, 1981·19 cites·5 claims
- 1460US5223241AMethod for early detection of allograft rejectionGEN HOSPITAL CORP·Filed 1991·Granted Jun 29, 1993·25 cites·11 claims
- 1559US5675062ACellular basis of transplant arteriosclerosis in miceHARVARD COLLEGE·Filed 1995·Granted Oct 7, 1997·15 cites·32 claims
- 1659US4803167AMonoclonal antidigoxtin antibodiesGEN HOSPITAL CORP·Filed 1982·Granted Feb 7, 1989·15 cites·2 claims
- 1755US5811265AHybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and useGEN HOSPITAL CORP·Filed 1993·Granted Sep 22, 1998·19 cites·6 claims
- 1854US5116613AAntibody-thrombolytic agent product and method of useGEN HOSPITAL CORP·Filed 1985·Granted May 26, 1992·17 cites·8 claims
- 1951US5620688AMethods of inhibiting the activation of Factor XIIIBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Apr 15, 1997·11 cites·8 claims
- 2051US5453269AHeterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of useGEN HOSPITAL CORP·Filed 1992·Granted Sep 26, 1995·18 cites·5 claims
- 2150US2009012020A1Inhibiting formation of atherosclerotic lesionsLEE MU-EN·Filed 2007·Application pending·0 cites
- 2247US5443827AFibrin-targeted inhibitors of thrombinHARVARD COLLEGE·Filed 1993·Granted Aug 22, 1995·9 cites·14 claims
- 2345US5609869AHybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and useGEN HOSPITAL CORP·Filed 1995·Granted Mar 11, 1997·9 cites·5 claims
- 2445US5256413AMethod and use for site-specific activation of substancesGEN HOSPITAL CORP·Filed 1992·Granted Oct 26, 1993·10 cites·2 claims
- 2542US5372812AComposition and method for acceleration of clot lysisGEN HOSPITAL CORP·Filed 1992·Granted Dec 13, 1994·8 cites·11 claims
- 2640US5831031AAntibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1996·Granted Nov 3, 1998·1 cites·4 claims
- 2740US2002169151A1Inhibition of vascular smooth muscle cell proliferationFiled 2002·Application pending·0 cites
- 2839US2002128189A1Ubiquitination of the transcription factor E2AHARVARD COLLEGE·Filed 2001·Application pending·0 cites
- 2937US6576431B2Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 2001·Granted Jun 10, 2003·1 cites·2 claims
- 3037US5357042ASynthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivityGEN HOSPITAL CORP·Filed 1992·Granted Oct 18, 1994·5 cites·4 claims
- 3135US6280730B1Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1997·Granted Aug 28, 2001·1 cites·10 claims
- 3233US6136953ASmooth muscle cell LIM proteinHARVARD COLLEGE·Filed 1998·Granted Oct 24, 2000·1 cites·3 claims
- 3333US5767262ASmooth muscle cell LIM proteinHARVARD COLLEGE·Filed 1996·Granted Jun 16, 1998·1 cites·10 claims
- 3431US6258557B1Smooth muscle cell LIM promoterHARVARD COLLEGE·Filed 1997·Granted Jul 10, 2001·0 cites·16 claims
- 3524US6248933B1Cellular basis of vascular-graft stenosisHARVARD COLLEGE·Filed 1998·Granted Jun 19, 2001·2 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →